These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 10505042)

  • 21. Preclinical evaluation of a radiosensitizing effect of gemcitabine in p53 mutant and p53 wild type bladder cancer cells.
    Fechner G; Perabo FG; Schmidt DH; Haase L; Ludwig E; Schueller H; Blatter J; Mller SC; Albers P
    Urology; 2003 Feb; 61(2):468-73. PubMed ID: 12597983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines.
    Edelman MJ; Quam H; Mullins B
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):141-4. PubMed ID: 11561780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of a non-functional p53 affects the sensitivity of cancer cells to gemcitabine.
    Galmarini CM; Clarke ML; Falette N; Puisieux A; Mackey JR; Dumontet C
    Int J Cancer; 2002 Feb; 97(4):439-45. PubMed ID: 11802204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of growth inhibition and apoptosis in pancreatic cancer cells by auristatin-PE and gemcitabine.
    Li Y; Singh B; Ali N; Sarkar FH
    Int J Mol Med; 1999 Jun; 3(6):647-53. PubMed ID: 10341297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 gene status modulates the chemosensitivity of non-small cell lung cancer cells.
    Lai SL; Perng RP; Hwang J
    J Biomed Sci; 2000; 7(1):64-70. PubMed ID: 10644891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemotherapy resistance and oncogene expression in non-small cell lung cancer.
    d'Amato TA; Landreneau RJ; Ricketts W; Huang W; Parker R; Mechetner E; Yu IR; Luketich JD
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):352-63. PubMed ID: 17258563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paclitaxel alters the expression and specific activity of deoxycytidine kinase and cytidine deaminase in non-small cell lung cancer cell lines.
    Shord SS; Patel SR
    J Exp Clin Cancer Res; 2009 Jun; 28(1):76. PubMed ID: 19500405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors.
    McDonald AC; Brown R
    Br J Cancer; 1998 Sep; 78(6):745-51. PubMed ID: 9743293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of Her-2/neu in human lung cancer cell lines by immunohistochemistry and fluorescence in situ hybridization and its relationship to in vitro cytotoxicity by trastuzumab and chemotherapeutic agents.
    Bunn PA; Helfrich B; Soriano AF; Franklin WA; Varella-Garcia M; Hirsch FR; Baron A; Zeng C; Chan DC
    Clin Cancer Res; 2001 Oct; 7(10):3239-50. PubMed ID: 11595720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells.
    Dyshlovoy SA; Madanchi R; Hauschild J; Otte K; Alsdorf WH; Schumacher U; Kalinin VI; Silchenko AS; Avilov SA; Honecker F; Stonik VA; Bokemeyer C; von Amsberg G
    BMC Cancer; 2017 Feb; 17(1):93. PubMed ID: 28143426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retention of the in vitro radiosensitizing potential of gemcitabine under anoxic conditions, in p53 wild-type and p53-deficient non-small-cell lung carcinoma cells.
    Wouters A; Pauwels B; Lambrechts HA; Pattyn GG; Ides J; Baay M; Meijnders P; Peeters M; Vermorken JB; Lardon F
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):558-66. PubMed ID: 21377279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased radiation-induced apoptosis and altered cell cycle progression of human lung cancer cell lines by antisense oligodeoxynucleotides targeting p53 and p21(WAF1/CIP1).
    Sak A; Wurm R; Elo B; Grehl S; Pöttgen C; Stüben G; Sinn B; Wolf G; Budach V; Stuschke M
    Cancer Gene Ther; 2003 Dec; 10(12):926-34. PubMed ID: 14712319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma.
    Voigt W; Kegel T; Weiss M; Mueller T; Simon H; Schmoll HJ
    J Cancer Res Clin Oncol; 2005 Sep; 131(9):585-90. PubMed ID: 16021466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.
    Jensen PB; Holm B; Sorensen M; Christensen IJ; Sehested M
    Br J Cancer; 1997; 75(6):869-77. PubMed ID: 9062409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The expression of Bcl-XL, Bcl-XS and p27Kip1 in topotecan-induced apoptosis in hepatoblastoma HepG2 cell line.
    Zhang J; Cheng C; He CL; Zhou YJ; Cao Y
    Cancer Invest; 2008 Jun; 26(5):456-63. PubMed ID: 18568767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Piceatannol Enhances the Antitumor Efficacy of Gemcitabine in Human A549 Non-Small Cell Lung Cancer Cells.
    Xu B; Tao ZZ
    Oncol Res; 2014; 22(4):213-217. PubMed ID: 26351210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma.
    Lam W; Bussom S; Cheng YC
    Mol Cancer Ther; 2009 Feb; 8(2):415-23. PubMed ID: 19208827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis.
    Bruzzese F; Rocco M; Castelli S; Di Gennaro E; Desideri A; Budillon A
    Mol Cancer Ther; 2009 Nov; 8(11):3075-87. PubMed ID: 19887547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Traditional Chinese medicine Ze-Qi-Tang formula inhibit growth of non-small-cell lung cancer cells through the p53 pathway.
    Xu Z; Zhang F; Zhu Y; Liu F; Chen X; Wei L; Zhang N; Zhou Q; Zhong H; Yao C; Zhu X; Gong C; Zhu S; Zou C
    J Ethnopharmacol; 2019 Apr; 234():180-188. PubMed ID: 30660711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gemcitabine sensitizes lung cancer cells to Fas/FasL system-mediated killing.
    Siena L; Pace E; Ferraro M; Di Sano C; Melis M; Profita M; Spatafora M; Gjomarkaj M
    Immunology; 2014 Feb; 141(2):242-55. PubMed ID: 24128051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.